July 19, 2023
Pfizer Inc. and a rival company launched by two of its former executives on Wednesday stipulated to the dismissal of a trade secrets dispute, pounding a predictable yet final nail through the case that once saw a judge force Pfizer to reveal its communications with the FBI to the defendants.
May 30, 2023
Pfizer and a company formed by two of its former executives told a Connecticut federal court they are in the process of inking a deal that would end a suit accusing the ex-executives of stealing research.
February 06, 2023
Pfizer must disclose a tranche of 35 emails and text messages that the pharmaceutical giant exchanged with the FBI before filing a civil trade secrets lawsuit against two former executives who quit and formed a new company, a U.S. magistrate judge in Connecticut has ruled.
January 25, 2023
Questioning the lack of a key affidavit and the sufficiency of a deposition, a federal magistrate judge seemed inclined to reject at least some of Pfizer's arguments to shielding its communications with the FBI from two former executives the company has accused of stealing drug research.
January 19, 2023
Pfizer is set to tell a Connecticut federal court next week that communications between its lawyers and the FBI shouldn't be disclosed in its trade secrets suit accusing former executives of stealing diabetes and cancer medication research. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
March 22, 2022
Two former Pfizer executives have hit back at the company's accusations that they swiped diabetes and cancer medication research, saying their new research has nothing to do with their work at Pfizer.
February 02, 2022
Pfizer has accused two former executives of stealing diabetes and cancer medication research for two biotechnology startups that they developed prior to their departure, according to a trade secrets suit filed Wednesday.